MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
MediGene Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 13.25M |
| December 31, 2023 | 12.48M |
| June 30, 2023 | 9.390M |
| December 31, 2022 | 7.780M |
| Date | Value |
|---|---|
| June 30, 2022 | 11.52M |
| December 31, 2021 | 15.13M |
| June 30, 2021 | 17.02M |
| December 31, 2020 | 22.27M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| InflaRx NV | 25.38M |
| BioNTech SE | 2.414B |
| Immatics NV | 254.72M |
| Arrowhead Pharmaceuticals, Inc. | 699.56M |
| Oncolytics Biotech, Inc. | 13.11M |